{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Hematologist","title":"VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a0ca7f60\"></iframe>","width":"100%","height":180,"duration":1341,"description":"In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical School and an expert in myeloid neoplasms. Their discussion focuses on the VERONA trial and its impact on the myelodysplastic syndromes community. ","thumbnail_url":"https://img.transistorcdn.com/UV_KyPwV-T-4orH0ygSBcFOjHh1uy0PhPRgI8Wyax7g/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzIxNjc1LzE2MzE1/NTM2MTEtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}